
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="../style.css">
    <title>Document</title>
</head>
<body>

<span class="table_title">False Negatives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>3</th>
      <td></td>
      <td>4 times daily<br>once daily</td>
      <td>Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg × 4 times daily + GGT 7680 mg once daily) in a week.</td>
    </tr>
    <tr>
      <th>5</th>
      <td></td>
      <td>4 times a day<br>daily<br>once a day</td>
      <td>AAP at 1000 once a day or 1000 mg × 4 times a day was administered in the presence or absence of GGT (7680 mg) daily.</td>
    </tr>
    <tr>
      <th>9</th>
      <td></td>
      <td>Daily</td>
      <td>Daily before going to bed, participants took two tablets, with 500 mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51 mg/tablet), for 14 subsequent days.</td>
    </tr>
    <tr>
      <th>10</th>
      <td></td>
      <td>every 4 weeks<br>once</td>
      <td>Haloperidol (38 mg/kg bw) was applied intramuscularly once every 4 weeks over 12 weeks beginning after 15 days of treatment with valerian [51].</td>
    </tr>
    <tr>
      <th>21</th>
      <td></td>
      <td>weekly</td>
      <td>With MTX doses between 7.5 and 15 mg weekly, this effect is moderate (AUC +28% with ASA, less for the others), and there is inter-individual variability.</td>
    </tr>
    <tr>
      <th>13</th>
      <td></td>
      <td>every study day</td>
      <td>Vital signs (blood pressure, pulse, oxygen saturation) were obtained on every study day.</td>
    </tr>
    <tr>
      <th>16</th>
      <td></td>
      <td>daily</td>
      <td>The patient was compliant regarding the attendance of appointments and in taking the medication, and maintained a therapeutic INR (1.7–2.5) on a maintenance daily dose of 1.875 mg warfarin with monthly INR monitoring.</td>
    </tr>
    <tr>
      <th>12</th>
      <td></td>
      <td>twice daily</td>
      <td>The following treatments were administered for 8 days each: placebo twice daily (treatment A), EGb 761® 120 mg twice daily (treatment B), and EGb 761® 240 mg in the morning and placebo in the evening (treatment C).</td>
    </tr>
    <tr>
      <th>15</th>
      <td></td>
      <td>daily</td>
      <td>daily for two weeks at morning and a single captopril dose (4.5 mg/200 g BW; p.o.)</td>
    </tr>
    <tr>
      <th>8</th>
      <td></td>
      <td>daily</td>
      <td>Recommended daily doses of valerian root extracts are about 600 mg, usually taken as capsules or tablets.</td>
    </tr>
    <tr>
      <th>17</th>
      <td></td>
      <td>daily</td>
      <td>However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin.</td>
    </tr>
    <tr>
      <th>14</th>
      <td></td>
      <td>multiple dosing</td>
      <td>Alternate study designs, including silibinin predosing and multiple dosing of raloxifene, could provide further insight into interaction potential.</td>
    </tr>
    <tr>
      <th>1</th>
      <td></td>
      <td>every 24 h</td>
      <td>The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated.</td>
    </tr>
    <tr>
      <th>18</th>
      <td></td>
      <td>single oral dose</td>
      <td>(B) Plasma obtained from the volunteer received single oral dose of 40 mg simvastatin.</td>
    </tr>
    <tr>
      <th>19</th>
      <td></td>
      <td>daily</td>
      <td>Many potentially hepatotoxic herbs are not studied extensively enough to determine a safe daily dose.</td>
    </tr>
    <tr>
      <th>0</th>
      <td></td>
      <td>repeated administration</td>
      <td>Biliary excretion, but not urinary excretion, of methotrexate decreased in the RGE repeated administration group, compared to that in the control group.</td>
    </tr>
    <tr>
      <th>2</th>
      <td></td>
      <td>4 times (8 tablets) per day</td>
      <td>To mimic the recommended dose based on the status of patients, AAP dose is suggested from 1000 mg to the maximum dose of 1000 mg × 4 times (8 tablets) per day for treatment of the common cold [22,23].</td>
    </tr>
    <tr>
      <th>20</th>
      <td></td>
      <td>every 2–3 days</td>
      <td>Another patient experienced liver injury after taking 500 mg leaf powder every 2–3 days as a laxative [117].</td>
    </tr>
  </tbody>
</table>
<span class="table_title">False Positives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>0</th>
      <td>1</td>
      <td></td>
      <td>Elliot et al.</td>
    </tr>
    <tr>
      <th>2</th>
      <td>1</td>
      <td></td>
      <td>Results of the reporter gene assays.</td>
    </tr>
    <tr>
      <th>1</th>
      <td>2</td>
      <td></td>
      <td>The AUC0–∞ of quinine was slightly reduced by about 9 %.</td>
    </tr>
  </tbody>
</table>

</body>
</html>
